Sperm DNA Fragmentation Index Influences Assisted Reproductive Technology Outcome: a Global Systemic Review and Thorough Meta-Analysis

C. Deng,T. Li,Y. Xie,Y. Guo,Q. Yang,X. Liang,G. Liu
DOI: https://doi.org/10.1016/j.fertnstert.2017.07.247
IF: 6.7
2017-01-01
Fertility and Sterility
Abstract:To determine whether sperm DNA fragmentation index(DFI) has any impact on assisted reproductive technology(ART) outcomes, including the rates of miscarriage, good quality embryos and clinical pregnancy. We collected large-scale data in our center and comprehensively searched studies regarding the rates of miscarriage, good quality embryos and clinical pregnancy, and then performed a systemic review and meta-analysis to assess the influence of DFI. We collected detailed data regarding 1333 IVF cycles performed at our center from August 2010 to August 2015 to explore the association between sperm DFI and ART outcomes. Our unpublished data were extracted for this meta-analysis. We comprehensively searched PubMed, Web of Science and Google Scholar for the period of to October 30, 2016. The following MeSH terms(spermatozoa, DNA fragmentation and abortion) and their combinations were searched in [titled/abstract].Inclusion and exclusion of the studies were completed according strict criteria. The methodological quality of retrospective studies was assessed using the modified Newcastle-Ottawa scale. Data from the included studies were extracted to explore whether DFI influences the rates of miscarriage, good quality embryos and clinical pregnancy. Above steps were completed by two authors independently and all disagreements were resolved by discussion and arbitration by the senior authors. The meta-analyses were performed using Review Manager 5.3 (Cochrane Collaboration, Oxford, UK).The heterogeneity of the effects and the relative risk between high DFI and low DFI groups were evaluated using Forest plots. Funnel plots produced using Stata SE 12.0 were used to assess potential publication bias. Including our unpublished data, a total of 31 studies were included. The included studies generally scored 6 or more on the Newcastle-Ottawa Quality Assessment Scale. The primary meta-analysis of 26 studies comprising 8173 couples showed a significantly higher miscarriage rate in the high DFI group than in the low DFI group [RR=1.76(1.31,2.37), P=0.002<0.01]. The meta-analysis of 8 studies comprising 17631 embryos revealed a significantly lower good quality embryo rate [RR=0.64(0.61, 0.67), P<0.00001]. The meta-analysis 13 studies comprising 3496 couples showed that the high DFI group had a significantly lower clinical pregnancy rate than the low DFI group [RR=0.77(0.69, 0.85), P<0.0001]. With such a large number of samples supported, we can safely conclude that high DFI does adversely affect ART outcome, although the mechanism involved remains to be determined. More well-designed studies exploring the association between DFI and ART outcome are desired, and a standard threshold of DNA damage needs to be established for various DNA assays in routine clinical use.
What problem does this paper attempt to address?